MJ347-81F4
A Strain MJ347-81 F4 has been found to produce two new cyclic thiazolyl peptide antibiotics, components A and B. Taxonomic studies including morphological and physiological characteristics and chemical analysis of whole cells of the producing strain revealed this microorganism to belong to genus Amycolatopsis, and so we designated the strain Amycolatopsis sp. MJ347-81 F4. After 10 to 12 days of fermentation, most of the antibacterial activity was present mainly in the mycelial cake and reached its maximum level. In comparison with reference compounds, A as the major component showed excellent in vitro activity against Gram-positive bacteria including highly methicillin-resistant Staphylococcus aureus (MRSA) and Enterococcus faecalis with MICs in the range of During the course of our investigation for the discovery of novel antibacterial antibiotics, especially those possessing potent activity against methicillin-resistant Staphylococcus aureus (MRSA), from microorganisms isolated from new soil samples, we found Amycolatopsis sp. MJ347-81 F4 to produce two new antibiotics, hereafter designated MJ347-81 F4 components A and B. The antibiotic complex was mainly present in the mycelial cake and it was extracted with acetone. The respective components were purified by solvent extraction and bioassay-directed fractionation employing a combina- and glycothiohexide is the presence of dehydroalanine in the former two and of cysteine derived moiety as the bicyclic bridgehead in the place of the serine derived moiety in the latter. The major component A was isolated in sufficient quantity to permit evaluation of its biological activity. Accordingly, in this paper, we describe the The isolation procedure, physico-chemical properties,
and structural elucidation will be described in a separate paper. as packed cell volume obtained from 10ml of the culture fluid after centrifugation at 2,800rpm for 10 minutes.
Materials and Methods

Microorganisms
In Vitro Susceptibility Testing and HPLC Analysis Antimicrobial activity was monitored as growth inhibition against Staphylococcus aureus FDA 209P by the paper disk method. Further, the potency of major component A in the fermentation broth was determined by reversed-phase HPLC using an Inertsil ODS-2 column with acetonitrile/tetrahydrofuran/0.01 % trifluoroacetic acid (22: 10:68) at a flow rate of 1.0 ml/minute with detection by UV absorption at 220 nm. The sample for assay by HPLC was prepared as follows: 2ml of acetone was added to I ml of the fermentation broth; and after having been stirred vigorously for 1 minute, the mixture was centrifuged at 3,100rpm for 5 minutes. quinones were MK-9 (H4), and a slight amount of MK-9 (H2) was also detected. This strain contained major amount of iso-branched 13-methyltetradecanoic acid (iso-15:0), cis-9, 10-dehydrohexadecanoic acid (cis-16:1), cis-9, 10-dehydrohepadecanoic acid (cis-17:1) as well as other minor components. The taxonomic properties mentioned above and particularly the chemotaxonomic results were in good accordance with those of genus THE JOURNAL OF ANTIBIOTICS 719 organism as Amycolatopsis sp. MJ347-81 F4, although the species was not determined. A typical time course for the production of component A is shown in Fig. 3 . As seen, the maximum yield (125units/ml) was obtained at culture day 11. The presence of component A in the culture broth was much less than a quarter of that in the mycelia. The antibacterial activity, as estimated by the inhibitory zone against S. aureus, paralleled the production of component A. Next we tested the productivity in the A-1 and F-1 medium used in glycothiohexide production22), because component A resembled closely glycothiohexide in structure as mentioned above. As a result, the maximum production of component A in the A-1 and F-1 medium was less than 1/4 and 1/2, respectively, of the amount in the medium used for component A.
Antibiotics MJ347-81 F4 components A and B are structurally related to cyclic thiazolyl peptides and have some structural similarity to these antibiotics. Compounds with closely related structures such as A-1025516), glycothiohexide17), S-5483218), GE-227019), thiostreptons20), and amythiamicin21) have been found, and are produced by Streptomyces sp., Sebekia sp., Micromonospora sp., Planobispora rosea, Streptomyces azureus, and Amycolatopsis sp., respectively. There are also examples of other similar compounds produced by microorganisms of different taxa. Accordingly, it seems that the biosynthesis system of thiazolyl peptide antibiotics occurs widely in microorganisms.
Antibiotic MJ347-81 F4 component A showed excellent in vitro activity against Gram-positive bacteria including methicillin-resistant S. aureus (MRSA) and E. faecalis, but was inactive against most Gram-negative bacteria ( Furthermore, it has been recently reported that plasmidmediated E. faecalis and E. faecium resistant to vancomycin pose serious clinical problems24,25). It will be interesting to determine whether these components will affect these strains or not. The evaluation of the in vivo efficacy of MJ347-81 F4 component A against MRSA and E. faecalis is now in progress. The antifungal Table 3 . Antimicrobial spectrum of MJ347-81 F4 component A.
Next we evaluated the mechanism of action of component A by assessing the effect of the compounds on thiostrepton (TS)-and amythiamicin (ATM)-resistant B. subtilis NRRL B-558. The thiazolyl-peptide antibiotics such as thiostrepton, thiopeptin, and siomycin are known to act on 50S ribosomal subunits, consequently inhibiting 
